Free Newsletter
FEATURES >> The most interesting logos in Pharma
Abbott settles TriCor antitrust claims for $22.5M
Twenty-three states reached a $22.5 million settlement against Abbott Laboratories and Fournier for blocking a cheaper substitute for the cholesterol-fighting drug TriCor. Report
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
SHARE
WITH: